NCT07191028View on ClinicalTrials.gov

Alzheimer's Disease THErapy With NEuroaid II

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Alzheimer's Disease Dementia
Interventions
DRUG

MLC 901

Oral capsule, 2 capsules 3 times a day for 12 months

DRUG

Placebo

Oral capsule, 2 capsules 3 times a day for 12 months

Trial Locations (1)

Unknown

National University Hospital Singapore, Singapore

All Listed Sponsors
collaborator

National University Hospital, Singapore

OTHER

lead

Moleac Pte Ltd.

INDUSTRY